The recently published Canadian guideline on alcohol use disorder (AUD) advances the
evidence-based management of AUD in Canada. 1 A novel addition is a strong …

4. Stokes PRA, Jokinen T, Amawi S, et al. Pharmacological treatment of mood disorders and
comorbid addictions: a systematic review and meta-analysis. Can J Psychiatry 2020; 65: 749 …

We thank Bahji and colleagues1 and Elefante and colleagues2 for their interest in the
guideline on the management of alcohol use disorder (AUD). 3 We appreci ate the …

Discussion Alcohol is used by about 75% of the population in Canada and is a major cause
of preventable disease, injury and death. 1 In 2017 alone, alcohol was implicated in 18 000 …

Co-occurring psychiatric and alcohol use disorders can have devastating personal and
societal effects, yet little evidence exists to guide clinical treatment. In the face of scant data …

As addiction psychiatrists in Canada, we are concerned that this blanket statement may
have a substantial impact on the treatment of patients with alcohol use disorder who have a …

The goal of this guideline1 is to improve the quality of care and treatment outcomes for
patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric …

As a family physician I see many patients with mood disorders and selective serotonin
reuptake inhibitors are an important therapeutic option for them. I have the clinical …

This issue of the Journal includes two articles that address treatment of alcohol dependence.
Pettinati et al.(1) report a 14-week, randomized controlled trial comparing naltrexone alone …

Methods The study reviewed pharmacotherapy studies for AUDs from January 1970 through
March 2014, including randomised clinical trials (RCTs) of at least 12 weeks duration in an …